BRCA1 and urinary bladder carcinoma: Regarding the BRCA1 DNA repair gene in urothelial cancer, Font et al. associated low BRCA1 expression with better response to neoadjuvant cisplatin-based chemotherapy (p = 0.01) and improved disease-free survival (p = 0.02) in patients with locally advanced bladder cancer [71].